Lactam derivatives as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme
申请人:——
公开号:US20040266751A1
公开(公告)日:2004-12-30
The present invention provides compounds of Formula (I):
1
or a stereoisomer or pharmaceutically acceptable salt form thereof, wherein the variables A, B, R
1
, R
2
, U, X, Y, Z, U
a
, X
a
, Y
a
, and Z
a
are defined are as defined herein, which are useful as inhibitors of matrix metalloproteinases (MMP), and/or TNF-&agr; converting enzyme (TACE), or a combination thereof.
本发明提供了公式(I)的化合物:1或其立体异构体或药学上可接受的盐形式,其中变量A,B,R1,R2,U,X,Y,Z,Ua,Xa,Ya和Za的定义如本文所定义,这些化合物可用作基质金属蛋白酶(MMP)和/或TNF-α转化酶(TACE)的抑制剂,或其组合。